Multiple myeloma: Almost all patients are cytogenetically abnormal

British Journal of Haematology

Volumn 94, Issue 2, 1996, Pages 217-227

  Zandecki, M ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cytogenetics; DNA content; Fluorescence in situ hybridization (FISH); Monoclonal gammopathy; Multiple myeloma

Indexed keywords

INTERLEUKIN 6; DNA;

ANEUPLOIDY; ARTICLE; B CELL LEUKEMIA; CANCER GROWTH; CANCER STAGING; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 19; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; CHROMOSOME REARRANGEMENT; CYTOGENETICS; DNA CONTENT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE TRANSLOCATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INCIDENCE; MOLECULAR GENETICS; MONOSOMY; MULTIPLE MYELOMA; PATHOPHYSIOLOGY; PLASMA CELL; PRIORITY JOURNAL; TRISOMY; X CHROMOSOME; FEMALE; GENETICS; MALE; PATHOLOGY; REVIEW;

CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; DNA; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MULTIPLE MYELOMA; PLASMA CELLS;

EID: 0030211192     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-2939.x     Document Type: Article

References (86)

1. Anderson, K.C., Jones, R.M., Morimoto, C., Leavitt, P. & Barut, B.A. (1989) Response patterns of purified myeloma cells to hematopoietic growth factors. Blood, 73, 1915-1921.
2. Ankathil, R., Madhavan, J., Gandadharan, V.P., Pillai, G.R. & Nair, M.K. (1995) Nonrandom karyotype abnormalities in 36 multiple myeloma patients. Cancer Genetics and Cytogenetics, 83, 71-74.
3. Barlogie, B., Alexanian, R., Dixon, D., Smith, L., Smallwood, L. & Delasalle, K. (1985) Prognostic implications of tumor cell DNA and RNA content in multiple myeloma. Blood, 66, 338-341.
4. Barlogie, B., Alexanian, R., Gehan, E.A., Smallwood, L., Smith, T. & Drewinko, B. (1983) Marrowcytometry and prognosis inmyeloma. Journal of Clinical Investigation, 72, 853-861.
5. Baurmann, H., Cherif, D. & Berger, R. (1993) Interphase cytogenetics by fluorescent in situ hybridization (FISH) for characterization of monosomy-7-associated myeloid disorders. Leukemia, 7, 384-387.
6. Bentz, M., Dohner, H., Huck, K., Schutz, B., Ganser, A., Joos, S., Du Manoir, S. & Lichter, P. (1995) Comparative genomic hybridization in the investigation of myeloid leukemias. Genes, Chromosomes and Cancer, 12, 193-200.
7. Bergui, L., Schena, M., Gaidano, G., Riva, M. & Caligaris-Cappio, F. (1989) Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. Journal of Experimental Medicine, 170, 613-620.
8. Bloomfield, C.D. & de la Chapelle, A. (1987) Chromosome abnormalities in acute nonlymphocytic leukemia: clinical and biological changes. Seminars in Oncology, 14, 372-383.
9. Brito-Babapulle, V. & Atkin, N.B. (1981) Break points in chromosome 1 abnormalities of 218 human neoplasms. Cancer Genetics and Cytogenetics, 4, 215-222.
10. Bunn, P.A., Krasnow, S., Makuch, R.W., Schlam, M.L. & Schechter, G.P. (1982) Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: clinical implications. Blood, 59, 528-535.
11. Chen, K.C., Bevan, P.C. & Matthews, J.G. (1986) Analysis of G banded karyotypes in myeloma cells. Journal of Clinical Pathology, 39, 260-266.
12. Cherif,D. & Berger, R. (1990) New localizationsof VH sequences by in situ hybridization with biotinylated probe. Genes, Chromosomes and Cancer, 2, 103-108.
13. Cigudosa, J.C., Calasanz, J., Odero, M.D., Prosper, F., Etxaniz, A., Marin, J., Rifon, J., Gullon, A. & Rocha, E. (1994) Cytogenetic data in 41 patients with multiplemyeloma: karyotype and other clinical correlations. Cancer Genetics and Cytogenetics, 78, 210-213.
14. Dao, D.D., Sawyn, J.R., Epstein, J., Hoover, R.G., Barlogie, B. & Triest, G. (1994) Deletion of the retinoblastoma gene in multiple myeloma. Leukemia, 8, 1280-1284
15. Dewald, G.W. & Jenkins, R.B. (1991) Cytogenetic and molecular genetic studies of patients with monoclonal gammopathies. Neoplastic Diseases of the Blood, 2nd edn (ed. by Ph. Wiernik), pp.427-435. Churchill Livingstone, Edinburgh.
16. Dewald, G.W., Kyle, R.A., Hicks, G.A. & Greipp, P.R. (1985) The clinical significance of cytogenetic studies in 100 patients with multiplemyeloma, plasma cell leukemia, or amyloidosis. Blood, 66,380-385.
17. Drach, J., Angerler, J., Schuster, J., Rothermundt,C., Tahlhammer, R., Hass, O.A., Jäger, U., Fiegl, M., Geissler, K., Ludwig, H. & Huber, H. (1995a) Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood, 86, 3915-3921.
18. Drach, J., Schuster, J., Nowotny, H., Angerler, J., Rosenthal, F., Fiegl, M., Rothermundt, C., Gsur, A., Jäger, U., Heinz, R., Lechner, K., Ludwig, H. & Huber, H. (1995b) Multiplemyeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer Research, 55, 3854-3859.
19. Dubinsky, R., Amiel, A., Manor, Y., Radnay, Y., Feijgin, M., Ravid, M. & Lishner, M. (1995) Fluorescence in situ hybridization (FISH) for retrospective detection of trisomies 3 and 7 in multiple myeloma. Cancer Genetics and Cytogenetics, 83, 115-118.
20. Durie, B.G.M. (1992) Cellular and molecular genetic features of myeloma and related disorders. Hematology and Oncology Clinics of North America, 6, 463-477.
21. Facon, T., Laï, J.L., Nataf, E., Preudhomme, C., Zandecki, M., Hammad, M., Wattel, E., Jouet, J.P. & Bauters, F. (1993) Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients. British Journal of Haematology, 84, 743-746.
22. Ferti, A., Panani, A., Arapakis, G. & Raptis, S. (1984) Cytogenetic study in multiple myeloma. Cancer Genetics and Cytogenetics, 12, 247-253.
23. Flactif, M., Laï, J.L., Zandecki, M., Bernardi, F., Trillot,N., Bauters, F. & Facon, T. (1994) Two cases of translocation t(1;16)(p11:p11) in multiple myeloma: confirmation by chromosome painting. Cancer Genetics and Cytogenetics, 76, 10-13.
24. Flactif, M., Zandecki, M., Laï, J.L., Bernardi, F., Obein, V., Bauters, F. & Facon, T. (1995) Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidyin multiple myeloma. Leukemia, 9, 2109-2114.
25. Fruchart, C., Bastard, C., Chiesa, J., Rossi, A., Daragon, A., Stamatoullas, A., Tilly, H., Piguet, H. & Monconduit, M. (1995) Two different cytogenetic subgroups in multiple myeloma. Vth International Workshop on Multiple Myeloma, La Baule, abstract B9.
26. Fukuhara,S., Kita, K., Nasu, K., Kannagi, M., Kamezaki, T., Ohno, H., Yamazawa, M., Nishigori, M., Ushino, H., Yagita, M., Matsuo, N., Yamabe, H. & Tanaka, S. (1983) Karyotype evolution in B-cell lymphoid malignancy with an 8;14 translocation. International Journal of Cancer, 32, 555-560.
27. Garcia-Sanz, R., Orfao, A., Gonzalez, M., Moro, M.J., Hernandez, J.M., Ortega, F., Borrego, D., Carnero, M., Casanova, F., Jimenez, R., Portero, J.A. & San Miguel, J.F. (1995) Hyperdiploidy identifies a subgroup of multiplemyeloma (MM) patients with good prognosis. British Journal of Haematology, 90, 106-112.
28. Gould, J., Alexanian, R., Goodacre, A., Pathak, S., Hecht, B. & Barlogie, B. (1988) Plasma cell karyotype in multiple myeloma. Blood, 71, 453-456.
29. Hasageli Uner, A., Hutchinson, R.E. & Davey, F.R. (1994)Applications of in situ hybridization in the study of hematologic malignancies. Hematology/Oncology Clinics of North America, 8, 771-784.
30. Heim, S. & Mitelman, F. (1986) Secondary chromosome aberrations in the acute leukemias. Cancer Genetics and Cytogenetics, 22, 331-339.
31. Heim, S. & Mitelman,F. (1987) Chronic lymphoproliferative disorders. Cancer Cytogenetics, pp. 175-199. Alan R. Liss, New York.
32. Howell, R.T., Kitchen, C. & Standen, G.R. (1993) Telomeric associations in a patient with B-cell prolymphocytic leukemia. Genes, Chromosomes and Cancer, 7, 116-118.
33. Jonveaux, P. & Berger, R. (1992) Chromosome studies in plasma cell leukemia and multiplemyeloma in transformation. Genes, Chromosomes and Cancer, 4, 321-325.
34. Kallioniemi, A., Kallioniemi, O.P., Sudar, D., Rutovitz, D., Gray, J.W., Waldman, F. & Pinkel, D. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science, 258, 818-821.
35. Kawano, M., Hirano, T., Matsuda, T., Tada, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A. & Kishimoto, T. (1988) Autocrine generation and requirement of BSF-2/IL6 for human multiple myelomas. Nature, 332, 83-88.
36. Klein, B., Zhang, X.G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M. & Bataille, R. (1989) Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood, 73, 517-526.
37. Kowalczyk, J.R., Dmoszynska, A., Chobotow, M. & Sokolowska, B. (1991) Cytogenetic studies in patients with multiple myeloma. Cancer Genetics and Cytogenetics, 55, 173-179.
38. Kyle, R.A. (1993) 'Benign' monoclonal gammopathy: after 20 to 35 years of follow-up. Mayo Clinic Proceedings, 68, 26-36.
39. Laï, J.L., Fenaux, P., Zandecki, M., Nelken, B., Huart, J.J. & Deminatti, M. (1989) Cytogenetic studies in 30 patients with Burkitt lymphoma or L3 acute lymphoblastic leukaemia, with special reference to additional chromosome abnormalities. Annales de Genetique, 32, 26-32.
40. Laï, J.L., Zandecki, M., Mary, J.Y., Bernardi, F., Izydorczyk, V., Flactif, M., Morel, P., Jouet, J.P., Bauters, F. & Facon, T. (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood, 85, 2490-2497.
41. Latreille, J., Barlogie, B., Dosik, G., Johnston, D.A., Drewinko, B. & Alexanian, R. (1980) Cellular DNA content as a marker of human myeloma. Blood, 55, 403-408.
42. Latreille, J., Barlogie, B., Johnston, D., Drewinko, B. & Alexanian, R. (1982) Ploidy and proliferative characteristics in monoclonal gammopathies. Blood, 59, 43-51.
43. Lee,W., Han, K., Drut, R.M., Harris, C.P. & Meissner, L.F. (1993) Use of fluorescence in situ hybridization for retrospective detection of aneuploidyin multiplemyeloma. Genes, Chromosomes and Cancer, 7, 137-143.
44. Leo, R., Bocker, M., Peest, D., Hein, R., Bartl, R., Gessner, J.E., Selbach, J., Wacker, G. & Deicher, H. (1992) Multiparameter analyses of normal and malignant human plasma cells: CD38??, CD56?, CD54?, cIg?, is the common phenotype ofmyeloma cells. Annals of Hematology, 64, 132-139.
45. Lewis, J.P. & MacKenzie, M.R. (1984) Non-random chromosome aberrations associated with multiple myeloma. Hematology and Oncology, 2, 307-317.
46. Liang,W., Hopper, J.E. & Rowley, J.D. (1979) Karyotypic abnormalities and clinical aspects of patients with multiplemyeloma and related paraproteinemic disorders. Cancer, 44, 630-644.
47. Lisse, I.M., Drivsholm, A. & Christoffersen, P. (1988) Occurrence and type of chromosomal abnormalities in consecutive monoclonal gammopathies: correlation with survival. Cancer Genetics and Cytogenetics, 35, 27-36.
48. Mitelman, F. (1991) ISCN. Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature (ed. by F. Mitelman). S. Karger, Basel.
49. Mitelman, F. (1994) Catalogue of Chromosome Aberrations in Cancer, 5th edn. Wiley-Liss, New York.
50. Montecucco, C., Riccardi, A., Merlini, G., Mazzini, G., Giordano, P., Danova, M. & Ascari, E. (1984) Plasma cell DNA content in multiple myeloma and related paraproteinemic disorders: relationshipwith clinical and cytokinetic features. European Journal of Cancer and Clinical Oncology, 20, 81-90.
51. Morgan, R.J., Gonchoroff, N.J., Katzmann, J.A.,Witzig, T.E., Kyle, R.A. & Greipp, P.R. (1989) Detection of hypodiploidy using multiparameter flow cytometric analysis: a prognostic indicator in multiple myeloma. American Journal of Hematology, 30, 195-200.
52. Morris, C.M., Fitzgerald, P.H., Neville, M.A.,Wyld, R.J. & Beard, M.E.J. (1984) Does multisomy of chromosome 1q confer a proliferative advantage in B-cell acute lymphoblastic leukemia? Cancer, 54, 48-53.
53. Mugneret, F., Lizard, S., Aurias, A. & Turc-Carel, C. (1988) Chromosomes in Ewing's sarcoma. II. Nonrandom additional changes, trisomy 8 and der (16)(1;16). Cancer Genetics and Cytogenetics, 32, 239-245.
54. Mugneret, F., Sidaner, I., Favre, B., Manone, L., Maynadie, M., Caillot, D. & Solary, E. (1995) Der(16)t(1;16)(q10;p10) in multiple myeloma: a new non-random abnormality that is frequently associated with Burkitt's type translocations. Leukemia, 9, 277-281.
55. Nishida, K., Taniwaki, M., Misawa, S. & Abe, T. (1989a) Nonrandom rearrangement of chromosome 14 at band q32.33 in human lymphoid malignancies with mature B-cell phenotype. Cancer Research, 49, 1275-1281.
56. Nishida, K., Taniwaki, M., Misawa, S., Abe, T., Takino, T. & Fujii, H. (1987) Translocation (14;18) found in a patient with multiple myeloma. Cancer Genetics and Cytogenetics, 25, 375-377.
57. Nishida, K., Yashige, H., Meakawa, T., Fujii, H., Taniwaki, M., Horiike, S., Misawa, S., Inazawa, J. & Abe, T. (1989b) Chromosome rearrangement t(6;14)(p21.1;q32.3) in multiple myeloma. British Journal of Haematology, 71, 295-299.
58. Nishimoto, N., Ogata, A., Shima, Y., Tani, Y., Ogawa, H., Nakagawa, M., Sugiyama, H., Yoshizaki, K. & Kishimoto, T. (1994) Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, GP130. Journal of Experimental Medicine, 179, 1343-1347.
59. Pandis, N., Heim, S., Bardi, G., Idvall, I., Mandahl, N. & Mitelman, F. (1992)Whole-arm t(1;16) and i(1q) as sole anomalies identifygain of 1q as a primary chromosomal abnormality in breast cancer. Genes, Chromosomes and Cancer, 5, 235-238.
60. Philip, P., Drivsholm, A., Hansen, N.E., Jensen, M.K. & Killman, S.A. (1980) Chromosomes and survival in multiplemyeloma: a banding study of 25 cases. Cancer Genetics and Cytogenetics, 2, 243-257.
61. Ranni, N.S., Slavutsky, I., Weschler, A. & Brieux de Salum, S. (1987) Chromosome findings in multiple myeloma. Cancer Genetics and Cytogenetics, 25, 309-316.
62. Rowley, J.D. (1978) Abnormalities of chromosome no. 1: significance in malignant transformation. Virchows Archives, B: Cell Pathology, 29, 139-144.
63. Sandberg, A.A. (1990) The Chromosomes in Human Cancer and Leukemia, 2nd edn. Elsevier, New York.
64. Sandberg, A.A. & Turc-Carel, C. (1987) The cytogenetics of solid tumours: relation to diagnosis, classification and pathology. Cancer, 59, 387-395.
65. San Miguel, J.F., Garcia-Sanz, R., Gonzalez, M. & Orfao, A. (1995) Immunophenotype and DNA cell content in multiple myeloma. Clinical Haematology, 8, 735-759.
66. Sawyer, J.R., Waldron, J.A., Jagannath, S. & Barlogie, B. (1995) Cytogenetic findings in 200 patients with multiplemyeloma. Cancer Genetics and Cytogenetics, 82, 41-49.
67. Secker-Walker, L. (1990) Prognostic and biological significance of chromosome findings in acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics, 49, 1-13.
68. Shankey, T.V., Ravinovitch, P.S., Bagwell, B., Bauer, K.D., Duque, R.E., Hedley, D.W., Mayall, B.H. & Wheeless, L.L. (1993) Guidelines for implementation of clinical DNA cytometry. Cytometry, 14, 472-477.
69. Smadja, N.V., Louvet, C., Isnard, F., Dutel, J.L., Grange, M.J., Varette, C. & Krulik, M. (1995) Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques. British Journal of Haematology, 90, 619-624.
70. Smith, L., Barlogie, B. & Alexanian, R. (1986) Bioclonal and hypodiploid multiple myeloma. American Journal of Medicine, 80, 841-843.
71. Tafuri, A., Meyers, J., Lee, B.J. & Andreeff, M. (1991) DNA and RNA flow cytometric study in multiple myeloma: clinical correlations. Cancer, 67, 449-454.
72. Taniwaki, M., Nishida, K., Takashima, T., Nakagawa, H., Fujii, H., Tamaki, T., Shimazaki, C., Horiike, S., Misawa, S., Abe, T. & Kashima, K. (1994) Nonrandom chromosomal rearrangements of 14q32.3and 19p13.3and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. Blood, 84,2283-2290.
73. Tienhaara, A. & Pelliniemi,T.T. (1992) Flow cytometricDNA analysis and clinical correlations in multiple myeloma. American Journal of Clinical Pathology, 97, 322-330.
74. Travis, P., Sawyer, J., Lary, C., Hoover, R. & Barlogie, B. (1993) Translocation 11;14 and Bcl-1 gene abnormalities in multiple myeloma. Blood, 82, (Suppl. 1), 261a (abstract 1031).
75. Ueshima, Y., Fukuhara, S., Nagai, K., Takatsuki, K. & Ushino, H. (1983) Cytogenetic studies and clinical aspects of patients with plasma cell leukemia and leukemic macroglobulinemia. Cancer Research, 43, 905-912.
76. Van den Akker, T.W., De Glopper-Van der Veer, E., Michiels, J.J., Franken-Postma, E. & Hajemeijer, A. (1989) Direct correlation between plasma cell proliferation and the finding of cytogenetic abnormalities in multiple myeloma patients. Monoclonal Gammopathies II: Clinical Significance and Basic Mechanisms (ed. by J. Radl and B. Van Camp), pp. 109-111.
77. Van den Berghe, H. (1989) Chromosomes in plasma-cell malignancies. European Journal of Haematology, 43, (Suppl. 51), 47-51.
78. Van den Berghe, H., Louwagie, A., Broeckaert-Van Horshoven, A., David, G., Verwullghen, R., Michaux, J.L. & Sokal, G. (1979) Philadelphia chromosome in human multiple myeloma. Journal of the National Cancer Institute, 63, 11-15.
79. Van den Berghe, H., Vermaelen, K., Louwagie, A., Criel, A., Mecucci, C. & Vaerman, J.P. (1984) High incidence of chromosome abnormalities in IgG3 myeloma. Cancer Genetics and Cytogenetics, 11, 381-387.
80. Venti, G., Mecucci, C., Donti, E. & Tabilio, A. (1984) Translocation t(11;14) and trisomy 11q13-qter in multiple myeloma. Annales de Genetique, 27, 53-55.
81. Weh, H.J., Gutensohn, K., Selbach, J., Kruse, R., Wacker-Backhaus, G., Seeger, D., Fiedler, W., Fett, W. & Hossfeld, D.K. (1993) Karyotype in multiple myeloma and plasma cell leukaemia. European Journal of Cancer, 29A, 1269-1273.
82. Zandecki, M., Bernardi, F., Laï, J.L., Facon, T., Izydorczyk, V., Bauters, F. & Cosson, A. (1994) Image analysis in multiple myeloma at diagnosis: correlation with cytogenetic study. Cancer Genetics and Cytogenetics, 74, 115-119.
83. Zandecki, M., Facon, T. & Laï, J.L. (1996) Cytogénétique, contenu en ADN, et fluorescence in situ aprés hybridation dans le myélome multiple et les gammapathies monoclonales idiopathiques. Hématologie (in press).
84. Zandecki, M., Facon, T., Preudhomme, C., Vanrumbeke, M., Vachee, A., Quesnel, B., Laï, J.L., Cosson, A. & Fenaux, P. (1995a) The retinoblastoma gene (RB-1) status in multiple myeloma: a report on 35 cases. Leukemia and Lymphoma, 18, 497-503.
85. Zandecki, M., Obein, V., Bernardi, F., Soenen, V., Flactif, M., Laï, J.L., François, M. & Facon, T. (1995b) Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within plasma cells. British Journal of Haematology, 90, 693-696.
86. Zhang, X.G., Bataille, R., Jourdan, M., Saeland, S., Banchereau, J., Mannoni, P. & Klein, B. (1990) Granulocyte-macrophage colony stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood, 76, 2599-2604